Document Format Files
| Seq | Description | Document | Type | Size |
|---|---|---|---|---|
| 1 | F-1/A | tm2016252-9_f1a.htm | F-1/A | 5132168 |
| 2 | EXHIBIT 3.1 | tm2016252d8_ex3-1.htm | EX-3.1 | 287501 |
| 3 | EXHIBIT 3.2 | tm2016252d8_ex3-2.htm | EX-3.2 | 94609 |
| 4 | EXHIBIT 3.3 | tm2016252d8_ex3-3.htm | EX-3.3 | 104272 |
| 5 | EXHIBIT 3.5 | tm2016252d8_ex3-5.htm | EX-3.5 | 552149 |
| 6 | EXHIBIT 4.1 | tm2016252d8_ex4-1.htm | EX-4.1 | 168586 |
| 7 | EXHIBIT 10.1 | tm2016252d8_ex10-1.htm | EX-10.1 | 883666 |
| 8 | EXHIBIT 10.2 | tm2016252d8_ex10-2.htm | EX-10.2 | 268509 |
| 9 | EXHIBIT 10.3 | tm2016252d8_ex10-3.htm | EX-10.3 | 587956 |
| 10 | EXHIBIT 10.7 | tm2016252d8_ex10-7.htm | EX-10.7 | 189697 |
| 11 | EXHIBIT 10.12 | tm2016252d8_ex10-12.htm | EX-10.12 | 30747 |
| 12 | EXHIBIT 10.35 | tm2016252d13_ex10-35.htm | EX-10.35 | 41914 |
| 13 | EXHIBIT 10.36 | tm2016252d13_ex10-36.htm | EX-10.36 | 535554 |
| 14 | EXHIBIT 10.37 | tm2016252d13_ex10-37.htm | EX-10.37 | 261526 |
| 15 | EXHIBIT 14.1 | tm2016252d8_ex14-1.htm | EX-14.1 | 148169 |
| 16 | EXHIBIT 23.1 | tm2016252d8_ex23-1.htm | EX-23.1 | 3556 |
| 17 | GRAPHIC | lg_curevac-fpo.jpg | GRAPHIC | 79401 |
| 18 | GRAPHIC | lg_curevacfpo-4clr.jpg | GRAPHIC | 40504 |
| 19 | GRAPHIC | tm2016252-6_riderf42820.jpg | GRAPHIC | 40922 |
| 20 | GRAPHIC | tm2016252-6_riderg42820.jpg | GRAPHIC | 135900 |
| 21 | GRAPHIC | tm2016252d6-bc_induc4clr.jpg | GRAPHIC | 528620 |
| 22 | GRAPHIC | tm2016252d6-bc_kinet4clr.jpg | GRAPHIC | 993673 |
| 23 | GRAPHIC | tm2016252d6-bc_prelim4clr.jpg | GRAPHIC | 2141159 |
| 24 | GRAPHIC | tm2016252d6-bc_sars4clr.jpg | GRAPHIC | 201098 |
| 25 | GRAPHIC | tm2016252d6-cvcm.jpg | GRAPHIC | 135676 |
| 26 | GRAPHIC | tm2016252d6-diverse.jpg | GRAPHIC | 218699 |
| 27 | GRAPHIC | tm2016252d6-fc_cohorts4clr.jpg | GRAPHIC | 684971 |
| 28 | GRAPHIC | tm2016252d6-fc_product4clr.jpg | GRAPHIC | 163875 |
| 29 | GRAPHIC | tm2016252d6-lc_cv72024c.jpg | GRAPHIC | 483505 |
| 30 | GRAPHIC | tm2016252d6-mrna.jpg | GRAPHIC | 161398 |
| 31 | GRAPHIC | tm2016252d6-ph_lesions4clr.jpg | GRAPHIC | 279473 |
| 32 | GRAPHIC | tm2016252d6-ph_tumor4clr.jpg | GRAPHIC | 616245 |
| 33 | GRAPHIC | tm2016252d6-production.jpg | GRAPHIC | 127751 |
| 34 | GRAPHIC | tm2016252d6-successive.jpg | GRAPHIC | 274950 |
| 35 | GRAPHIC | tm2016252d6-tbl_prefer4clr.jpg | GRAPHIC | 571212 |
| 36 | GRAPHIC | tm2016252d6-tbl_prelim4clr.jpg | GRAPHIC | 596008 |
| 37 | GRAPHIC | tm2016252d6_bc-activfpo4c.jpg | GRAPHIC | 229630 |
| 38 | GRAPHIC | tm2016252d6_bc-levelsfpo4c.jpg | GRAPHIC | 185529 |
| 39 | GRAPHIC | tm2016252d6_bc-lungfpoo4c.jpg | GRAPHIC | 250006 |
| 40 | GRAPHIC | tm2016252d6_bc-opt3endfpo4c.jpg | GRAPHIC | 137075 |
| 41 | GRAPHIC | tm2016252d6_bc-optorffpo4c.jpg | GRAPHIC | 160928 |
| 42 | GRAPHIC | tm2016252d6_bc-optutrfpo4c.jpg | GRAPHIC | 117502 |
| 43 | GRAPHIC | tm2016252d6_bc-servntfpoo4c.jpg | GRAPHIC | 317224 |
| 44 | GRAPHIC | tm2016252d6_fc-bodyfpo4c.jpg | GRAPHIC | 394911 |
| 45 | GRAPHIC | tm2016252d6_fc-dosek.jpg | GRAPHIC | 168274 |
| 46 | GRAPHIC | tm2016252d6_fc-exploongfpo.jpg | GRAPHIC | 223595 |
| 47 | GRAPHIC | tm2016252d6_fc-liverfpo4c.jpg | GRAPHIC | 124269 |
| 48 | GRAPHIC | tm2016252d6_fc-prodesfpo4c.jpg | GRAPHIC | 188729 |
| 49 | GRAPHIC | tm2016252d6_fc-retinafpo4c.jpg | GRAPHIC | 277281 |
| 50 | GRAPHIC | tm2016252d6_fc-rnaooptfpo.jpg | GRAPHIC | 188317 |
| 51 | GRAPHIC | tm2016252d6_fc-sequence4c.jpg | GRAPHIC | 167979 |
| 52 | GRAPHIC | tm2016252d6_fc-therafpo4c.jpg | GRAPHIC | 726221 |
| 53 | GRAPHIC | tm2016252d6_fc-transfpo4c.jpg | GRAPHIC | 512034 |
| 54 | GRAPHIC | tm2016252d6_lc-abscofpo4c.jpg | GRAPHIC | 179721 |
| 55 | GRAPHIC | tm2016252d6_lc-aminofpo4c.jpg | GRAPHIC | 171145 |
| 56 | GRAPHIC | tm2016252d6_lc-dfpo4c.jpg | GRAPHIC | 74949 |
| 57 | GRAPHIC | tm2016252d6_lc-gfpo4c.jpg | GRAPHIC | 83627 |
| 58 | GRAPHIC | tm2016252d6_lc-half2fpo4c.jpg | GRAPHIC | 148797 |
| 59 | GRAPHIC | tm2016252d6_lc-halffpo4c.jpg | GRAPHIC | 496744 |
| 60 | GRAPHIC | tm2016252d6_lc-influenfpo4c.jpg | GRAPHIC | 384598 |
| 61 | GRAPHIC | tm2016252d6_lc-modimfpo4c.jpg | GRAPHIC | 125271 |
| 62 | GRAPHIC | tm2016252d6_lc-prodesfpo4c.jpg | GRAPHIC | 103023 |
| 63 | GRAPHIC | tm2016252d6_lc-rituxfpo4c.jpg | GRAPHIC | 115145 |
| 64 | GRAPHIC | tm2016252d6_lc-survfpo4c.jpg | GRAPHIC | 197463 |
| 65 | GRAPHIC | tm2016252d6_lc-tumor2fpo4c.jpg | GRAPHIC | 180661 |
| 66 | GRAPHIC | tm2016252d6_lc-tumorfpo4c.jpg | GRAPHIC | 152552 |
| 67 | GRAPHIC | tm2016252d6_ph-buildfpo4c.jpg | GRAPHIC | 2379805 |
| 68 | GRAPHIC | tm2016252d6_ph-ccl4fpo4c.jpg | GRAPHIC | 551026 |
| 69 | GRAPHIC | tm2016252d6_ph-curevac4clr.jpg | GRAPHIC | 1604041 |
| 70 | GRAPHIC | tm2016252d6_ph-melanfpo4c.jpg | GRAPHIC | 250665 |
| 71 | GRAPHIC | tm2016252d6_ph-metafpo4c.jpg | GRAPHIC | 199853 |
| 72 | GRAPHIC | tm2016252d6_ph-pretrefpo4c.jpg | GRAPHIC | 130174 |
| 73 | GRAPHIC | tm2016252d6_riderbofa42820.jpg | GRAPHIC | 387706 |
| 74 | GRAPHIC | tm2016252d6_sc-25hcfpo4c.jpg | GRAPHIC | 178879 |
| 75 | GRAPHIC | tm2016252d6_sc-areabuff.jpg | GRAPHIC | 636142 |
| 76 | GRAPHIC | tm2016252d6_sc-cvcmfpo4c.jpg | GRAPHIC | 179561 |
| 77 | GRAPHIC | tm2016252d6_sc-vaclpnfpo.jpg | GRAPHIC | 303470 |
| 78 | GRAPHIC | tm2016252d8_ex14-1img001.jpg | GRAPHIC | 4265 |
| Complete submission text file | 0001104659-20-089179.txt | 39267794 |
IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: F-1/A | Act: 33 | File No.: 333-240076 | Film No.: 201066996
SIC: 2834 Pharmaceutical Preparations
